American-Italian Cancer Foundation is located in New York, NY. The organization was established in 1986. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American-Italian Cancer Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, American-Italian Cancer Foundation generated $2.3m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 2.3% each year. All expenses for the organization totaled $1.8m during the year ending 06/2023. While expenses have increased by 1.2% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, American-Italian Cancer Foundation has awarded 68 individual grants totaling $3,491,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO SUPPORT CANCER RESEARCH, EDUCATION AND EARLY DETECTION, (CONT. ON SCHEDULE O)EMPHASIZING THE UNIQUE RESOURCES OF ITALY & USA, RECOGNIZING WORLD-CLASS SCIENTIFIC EXCELLENCE IN MEDICINE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MOBILE NO-COST BREAST CANCER SCREENING PROGRAM - PROVIDES MOBILE BREAST CANCER SCREENING, OUTREACH AND EDUCATION TO ECONOMICALLY DISADVANTAGED AND MEDICALLY UNDERSERVED WOMEN IN NEW YORK CITY.
POST-DOCTORAL FELLOWSHIP PROGRAM - PROVIDES FINANCIAL SUPPORT FOR THE POST-DOCTORAL RESEARCH OF PROMISING YOUNG SCIENTISTS WHO PURSUE RESEARCH AND ADVANCED TRAINING IN COLLABORATION WITH MENTORS AT MAJOR CANCER CENTERS IN THE US.
CANCER EDUCATION AND AWARDS - THE PRIZE FOR SCIENTIFIC EXCELLENCE IN MEDICINE HAS BEEN ESTABLISHED TO RECOGNIZE IMPORTANT DISCOVERIES IN CANCER BIOLOGY, PREVENTION, DIAGNOSIS AND/OR TREATMENT. IT IS AWARDED IN TWO CATEGORIES: EXCELLENCE IN BASIC SCIENCE CANCER RESEARCH AND EXCELLENCE IN CLINICAL ONCOLOGY. EACH WINNER IS AWRDED $50,000.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Daniele D Bodini Chairman | OfficerTrustee | 3 | $0 |
Philip Olivetti Secretary | OfficerTrustee | 3 | $0 |
Francesca Bodini Director | Trustee | 3 | $0 |
Gian Andrea Botta Director | Trustee | 3 | $0 |
Alberto Cribiore Director | Trustee | 3 | $0 |
Claudio Del Vecchio Director | Trustee | 3 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Multi-diagnostic Services Inc Medical Provider | 6/29/20 | $264,328 |
Extensis Payroll Provider | 6/29/20 | $376,495 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $1,249,990 |
Related organizations | $0 |
Government grants | $557,125 |
All other contributions, gifts, grants, and similar amounts not included above | $421,629 |
Noncash contributions included in lines 1a–1f | $2,523 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,228,744 |
Total Program Service Revenue | $0 |
Investment income | $37,007 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $45,428 |
Net Income from Fundraising Events | -$29,935 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,291,176 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $587,000 |
Grants and other assistance to domestic individuals. | $125,000 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $175,165 |
Compensation of current officers, directors, key employees. | $8,348 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $208,000 |
Pension plan accruals and contributions | $208 |
Other employee benefits | $1,589 |
Payroll taxes | $12,447 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $46,839 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $175 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $19,757 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $70,218 |
Insurance | $39,302 |
All other expenses | $0 |
Total functional expenses | $1,752,467 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $117,736 |
Savings and temporary cash investments | $2,697,094 |
Pledges and grants receivable | $382,996 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $35,935 |
Investments—publicly traded securities | $2,557,541 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $61,469 |
Total assets | $5,852,771 |
Accounts payable and accrued expenses | $162,025 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $162,025 |
Net assets without donor restrictions | $4,747,155 |
Net assets with donor restrictions | $943,591 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $5,852,771 |
Over the last fiscal year, American-Italian Cancer Foundation has awarded $587,000 in support to 11 organizations.
Grant Recipient | Amount |
---|---|
ALBERT EINSTEIN COLLEGE OF MEDICINE PURPOSE: CANCER RESEARCH | $40,000 |
COLD SPRING HARBOR LABORATORY PURPOSE: CANCER RESEARCH | $40,000 |
DANA-FARBER CANCER INSTITUTE PURPOSE: CANCER RESEARCH | $80,000 |
COLUMBIA UNIVERSITY PURPOSE: CANCER RESEARCH | $40,000 |
MASSACHUSETTS GENERAL HOSPITAL PURPOSE: CANCER RESEARCH | $120,000 |
MASSACHSETTS INSTITUTE OF TECHNOLOGY PURPOSE: CANCER RESEARCH | $27,000 |